rotenone has been researched along with Carcinoma, Lewis Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, D; Lee, HE; Lee, HY; Lee, SH; Lee, YM; Nguyen, MP | 1 |
| Chen, L; Chen, X; Duan, X; Fu, A; Hu, J; Wang, Y; Wei, Y; Xiao, W; Ye, H; Ye, X | 1 |
2 other study(ies) available for rotenone and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Deguelin inhibits vasculogenic function of endothelial progenitor cells in tumor progression and metastasis via suppression of focal adhesion.
Topics: Actins; Angiogenesis Inhibitors; Animals; Apoptosis; Carcinogenesis; Carcinoma, Lewis Lung; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemoprevention; Endothelial Progenitor Cells; Enzyme Activation; Focal Adhesion Protein-Tyrosine Kinases; Focal Adhesions; G1 Phase Cell Cycle Checkpoints; Green Fluorescent Proteins; Humans; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Protein Serine-Threonine Kinases; Rotenone; Xenograft Model Antitumor Assays | 2015 |
Deguelin--an inhibitor to tumor lymphangiogenesis and lymphatic metastasis by downregulation of vascular endothelial cell growth factor-D in lung tumor model.
Topics: Animals; Carcinoma, Lewis Lung; Cell Growth Processes; Cell Movement; Down-Regulation; Endothelial Cells; Female; Humans; Lymphangiogenesis; Lymphatic Metastasis; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; RNA, Messenger; Rotenone; Vascular Endothelial Growth Factor D | 2010 |